Close Menu

NEW YORK – When the US Food Administration granted the first Emergency Use Authorization for a saliva-based SARS-CoV-2 PCR test to the Rutgers Clinical Genomics Laboratory at RUCDR Infinite Biologics in April, many expected that other assays using saliva samples would quickly follow and scale to large numbers.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.